Filters close
Released: 20-Feb-2024 10:05 AM EST
Association for Molecular Pathology Releases Survey Findings and Recommendations to Improve Implementation of European Union’s In Vitro Diagnostic Regulation
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the results of its Impacts of the European Union (EU) In Vitro Diagnostic Regulation (IVDR) Survey. The anonymous survey was created and administered to molecular diagnostics professionals around the world to determine current levels of understanding, assess broad implications, and identify future trends related to the new regulation.

Released: 20-Dec-2023 9:05 AM EST
Association for Molecular Pathology Publishes Best Practice Guidance for Designing and Utilizing Slice Testing Approach for Diagnostics
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has published a report that explores specific considerations for a slice testing strategy for diagnostics, including gene selection, analytic performance, coverage, quality, and interpretation.

Released: 23-Oct-2023 1:05 AM EDT
Association for Molecular Pathology Appoints Lauren S. Menser as Chief Executive Officer
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today announced the appointment of Lauren S. Menser, CAE, as its Chief Executive Officer, effective January 3, 2024.

Released: 12-Oct-2023 9:05 AM EDT
Association for Molecular Pathology Publishes Best Practice Recommendations for Liquid Biopsy Assay Validations
Association for Molecular Pathology

The Association for Molecular Pathology has published best practice recommendations for validating and reporting clinical circulating tumor DNA (ctDNA) or liquid biopsy assays and their related scientific publications.

Released: 28-Sep-2023 10:45 AM EDT
Association for Molecular Pathology Announces 2023 Award Recipients
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award.

Released: 26-Sep-2023 12:05 PM EDT
Association for Molecular Pathology Publishes Report on Use of Multiplex Panels for Diagnosing Infectious Diseases
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has published a review of the current benefits and challenges to using multiplex PCR panels for the detection of microbial pathogens from gastrointestinal, central nervous system, lower respiratory tract, and joint specimens.

Released: 10-Jul-2023 10:05 AM EDT
Association for Molecular Pathology Publishes Clinical CYP3A4 and CYP3A5 Genotyping Assay Recommendations
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.

Released: 13-Jun-2023 10:20 AM EDT
AMP Presents Xavier Becerra with Champion for Innovation Award on 10th Anniversary of Landmark Supreme Court Ruling
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) today awarded Xavier Becerra, US Secretary of the Department of Health and Human Services, with its Champion for Innovation Award. Secretary Becerra was recognized for his 30-year career in public service and his ongoing commitment to protecting patient access to high-quality, affordable care. The award presentations coincides with the 10th anniversary of the Supreme Court’s landmark decision invalidating gene patents in Association for Molecular Pathology et al. v. Myriad Genetics, Inc. et al.

Released: 18-May-2023 11:05 AM EDT
AMP Offers Evidence-Based Recommendations for Next-Generation Sequencing Germline Variant Confirmation
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has published a report that was designed to establish recommendations for standardizing orthogonal confirmation practices for germline variants detected by next-generation sequencing (NGS) in The Journal of Molecular Diagnostics.

Released: 23-Dec-2022 3:05 PM EST
Association for Molecular Pathology Commends Congress on Decision to Not Include VALID Act in Consolidated Appropriations Act of 2023
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) applauds Congress for reaching an agreement on the Consolidated Appropriations Act of 2023 and recognizing that it was not the appropriate mechanism for advancing the Verifying Accurate Leading-edge IVCT Development (VALID) Act. The VALID Act proposed dramatic oversight modifications that would have been disruptive to clinical testing laboratories and harmful to patients throughout the U.S.

Released: 13-Dec-2022 3:55 PM EST
AMP Assesses Clinical Implementation of Past Standards and Guidelines for Interpretation and Reporting of Sequence Variants in Cancer
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, has published a report that was designed to assess clinical adoption, identify classification inconsistencies, and evaluate implementation barriers for the 2017 report, “Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.” The AMP manuscript, “Assessments of Somatic Variant Classification Using the AMP/ASCO/CAP Guidelines” was released online ahead of publication in The Journal of Molecular Diagnostics.

Released: 18-Oct-2022 11:00 AM EDT
Association for Molecular Pathology Offers Recommendations for In Silico Approaches for Validating Next-Generation Sequencing Analysis Pipelines
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, has published “Recommendations for the Use of In Silico Approaches for Next Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American Pathologists.”

Released: 3-Oct-2022 2:50 PM EDT
Association for Molecular Pathology Announces 2022 Award Recipients
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostics professional society, today announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. These prestigious accolades will be presented this November during AMP’s 2022 Annual Meeting & Expo in Phoenix, Arizona.

Released: 25-Aug-2022 2:40 PM EDT
AMP Recommends Minimum Set of Pharmacogenetic Alleles to Guide Design, Development, and Validation of Clinical TPMT and NUDT15 Genotyping Assays
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical TPMT and NUDT15 genotyping assays, promote standardization of testing across different laboratories and improve patient care.

Released: 19-Apr-2022 1:25 PM EDT
Report Offers Recommendations to Improve Clinical Testing Economics and Inform National Preparation Strategies for Future Public Health Emergencies
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) today released a report entitled “Economics of Clinical Testing during a Public Health Emergency: Lessons Learned from Two Years of COVID-19.” The detailed assessment reflects on the first two years of the COVID-19 pandemic, dissects various coding, coverage, and pricing policies, and provides 15 recommendations to help prevent or at least mitigate these same economic challenges in the future.

Released: 5-Apr-2022 1:05 PM EDT
Association for Molecular Pathology Hosted a Congressional Briefing to Urge Lawmakers to Consider the VALID Act of 2021 Separately from the Medical Device User Fee Agreement Process
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, called on Congress to allow for a thorough evaluation of the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021, or any other legislation to change regulations for laboratory developed testing procedures (LDPs). Representatives from AMP, the American Association for Clinical Chemistry (AACC), the American College of Medical Genetics and Genomics (ACMG), and the Association of Pathology Chairs (APC) hosted a congressional briefing yesterday to educate lawmakers about how diagnostic tests are currently regulated and the substantial impact the VALID Act would have on clinical testing laboratories, healthcare providers, and patients throughout the U.S.

Released: 9-Feb-2022 11:20 AM EST
Association for Molecular Pathology and The American Society for Investigative Pathology Announce New Editor-in-Chief for The Journal of Molecular Diagnostics
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostics professional society, today announced the appointment of Ronald M. Przygodzki, MD as the incoming Editor-in-Chief of The Journal of Molecular Diagnostics (JMD). Barbara Zehnbauer, PhD, who has served with distinction as Editor-in-Chief since January 2015, will retire from the position effective March 1, 2022.

Released: 1-Nov-2021 4:05 PM EDT
Association for Molecular Pathology Announces 2021 Award Recipients
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostics professional society, today announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award.

Released: 1-Nov-2021 3:05 PM EDT
Association for Molecular Pathology Leaders Publish Recommendations to Improve Diagnostic Testing Response for Current COVID-19 Pandemic and Future Emerging Outbreaks
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today announced a new article in JAMA Health Forum.

Released: 29-Jul-2021 10:40 AM EDT
AMP Publishes Recommendations to Facilitate Widespread Adoption of Genetic Variant Data Sharing Practices
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) today released recommendations to support and facilitate sharing of variant data through the use of public repositories.

Released: 10-Jun-2021 1:00 PM EDT
AMP Recommends Minimum Set of Pharmacogenetic Alleles to Guide Clinical CYP2D6 Genotype Testing, Promote Standardization, and Improve Patient Care
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP2D6 assays, promote standardization of testing across different laboratories and improve patient care. The manuscript, “Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and European Society for Pharmacogenomics and Personalized Therapy,” was released online ahead of publication in The Journal of Molecular Diagnostics.

Released: 18-May-2021 1:00 PM EDT
Association for Molecular Pathology and Association of Pathology Chairs Call on Congress to Pass the Verified Innovative Testing in American Laboratories (VITAL) Act
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) and the Association of Pathology Chairs (APC) commend U.S. Senator Rand Paul (R-KY) for introducing legislation that would allow molecular pathology professionals to continue advancing and offering high-quality laboratory developed testing procedures (LDPs) for patient care. The Verified Innovative Testing in American Laboratories (VITAL) Act of 2021 would enhance transparency, preserve innovation, and ensure widespread patient access to essential medical services.

16-Mar-2021 10:00 AM EDT
New Association for Molecular Pathology Report Reignites Effort for Appropriate Reimbursement for Professional Analysis, Interpretation, and Reporting of Molecular Diagnostic Testing Procedures
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has released the results of its qualitative and quantitative “Analysis of Professional Work Effort in Molecular Test Interpretation Report.” More than 100 molecular professionals reported that their efforts spent on data analysis, interpretation, and reporting for molecular diagnostic tests were not sufficiently reimbursed. Respondents indicated that adequate reimbursement for these activities would improve patient care by increasing access to these essential medical services and enabling more data-driven treatment decisions.

Released: 23-Feb-2021 10:45 AM EST
Latest Association for Molecular Pathology Survey Findings Indicate Significant Decline in Molecular Testing for Cancer During COVID-19 Pandemic
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the preliminary results of its “Molecular Testing for Cancer during COVID-19” survey of clinical laboratories.

Released: 26-Jan-2021 10:05 AM EST
Association for Molecular Pathology Reinforces Continued Commitment to Improving National Diagnostic Testing Response for Current COVID-19 Pandemic and Future Emerging Outbreaks
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today announced the formation of the AMP COVID Response (ACR) Steering Committee to help coordinate and communicate the organization’s continued efforts to guide diagnostic testing during the ongoing COVID-19 pandemic and preparations for future emerging outbreaks.

Released: 8-Oct-2020 12:05 PM EDT
Association for Molecular Pathology Releases Preliminary Results to Second 2020 Nationwide SARS-CoV-2 Molecular Testing Survey
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has released the preliminary results of its August 2020 SARS-CoV-2 Testing Survey for clinical laboratories. Respondents are experiencing continued supply chain interruptions and significant staffing shortages, all while demand for molecular diagnostic testing continues to increase.

Released: 10-Sep-2020 12:05 PM EDT
Association for Molecular Pathology Announces 2020 Award Recipients
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostics professional society, today announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award.

Released: 21-Aug-2020 9:50 AM EDT
AMP Commends Department of Health and Human Services on Decision to Lessen Regulatory Burden on Laboratory Professionals
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostics professional society, commends the decision by the U.S. Department of Health and Human Services (HHS) to rescind the requirement for premarket review of laboratory developed testing procedures (LDPs) by the Food and Drug Administration (FDA).

Released: 28-May-2020 8:00 AM EDT
Association for Molecular Pathology Releases Preliminary Results to Nationwide SARS-CoV-2 Molecular Testing Survey
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the preliminary results of its April 2020 SARS-CoV-2 Testing Survey for clinical laboratories. The anonymous survey was created and administered to document clinical laboratory efforts and experiences. The results will be used to help inform future advocacy and clinical practice programs related to pandemic responses.

Released: 5-May-2020 3:40 PM EDT
AMP Recommends Minimum Set of Pharmacogenetic Alleles to Help Standardize Clinical Genotyping Testing for Warfarin Response
Association for Molecular Pathology

AMP has published consensus, evidence-based recommendations to aid in the design, validation and interpretation of clinical genotyping tests for the prediction of warfarin response. The manuscript, “Recommendations for Clinical Warfarin Sensitivity Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists,” was released online ahead of publication in The Journal of Molecular Diagnostics.

Released: 4-May-2020 12:55 PM EDT
AMP Expresses Support for Citizen Petition from the Coalition to Preserve Access to Pharmacogenomics Information
Association for Molecular Pathology

AMP has submitted a formal response in support of the Citizen Petition from Hyman, Phelps & McNamara, P.C. on behalf of the Coalition to Preserve Access to Pharmacogenomics (PGx) Information. The response builds on AMP’s PGx Best Practices Statement and includes a series of recommendations that will rectify recent FDA actions, which have suppressed important patient safety information.

Released: 18-Mar-2020 9:50 AM EDT
Association for Molecular Pathology Commends Senator Rand Paul for Introducing theVerified Innovative Testing in American Laboratories (VITAL) Act of 2020
Association for Molecular Pathology

AMP applauds US Senator Rand Paul (R-KY) for introducing new legislation to allow molecular pathology professionals to continue advancing and offering laboratory developed testing procedures (LDPs) for patient care. The Verified Innovative Testing in American Laboratories (VITAL) Act of 2020 clarifies the federal regulatory authority over LDPs and encourages the modernization of the existing Clinical Laboratory Improvement Amendments (CLIA), which are administered by the Centers for Medicare and Medicaid Services(CMS). The legislation was designed to enhance transparency, preserve innovation and ensure widespread patient access to essential medical services.

   
Released: 16-Mar-2020 9:00 AM EDT
Association for Molecular Pathology Calls on Senate to Close Coverage Gaps for Clinical Laboratory Testing in Families First Coronavirus Response Act
Association for Molecular Pathology

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released a statement on H.R. 6201, the Families First Coronavirus Response Act, as passed by the House of Representatives on March 14, 2020.

Released: 19-Sep-2019 9:00 AM EDT
Association for Molecular Pathology Announces 2019 Award Recipients
Association for Molecular Pathology

AMP has announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. These prestigious accolades will be presented this November during AMP’s 25th Annual Meeting & Expo in Baltimore, Maryland.

Released: 4-Sep-2019 9:45 AM EDT
AMP Recommends Clinical Pharmacogenomic Testing Best Practices to Preserve Broad Access and Improve Patient Care
Association for Molecular Pathology

AMP has published a new position statement for pharmacogenomic testing. Based on a recent assessment of the current market landscape, the statement includes a list of criteria for laboratories to follow for these types of tests to ensure responsible use, preserve broad access and improve patient care.

Released: 10-Jun-2019 11:05 AM EDT
AMP Bolsters Position on Consumer Genomic Testing
Association for Molecular Pathology

AMP has revised its official position for all consumer genomic testing. Based on a recent assessment of the current market landscape and privacy best practices, the latest position statement features an expanded list of conditions that must be met before AMP can support a clinically-meaningful test.

Released: 4-Jun-2019 10:50 AM EDT
Association for Molecular Pathology Expresses Serious Concerns with Congress’ Attempt to Resurrect Human Gene Patenting Debate and Reverse Settled Supreme Court Ruling
Association for Molecular Pathology

AMP has expressed serious concerns with Congress’ recent proposal to amend Section 101 of the Patent Act. If enacted, the draft legislation would overturn 150 years of patent case law and permit patenting of human genes and naturally-occurring associations between genes and diseases.

Released: 9-May-2019 10:05 AM EDT
AMP Recommends Minimum Set of Alleles for All Clinical CYP2C9 Genotyping Testing
Association for Molecular Pathology

A new joint report from AMP and CAP shares consensus, evidence-based recommendations to aid in the design and validation of clinical CYP2C9 assays, promote standardization of testing across different laboratories and improve patient care.

Released: 1-Feb-2019 12:00 PM EST
More than 60 Leading Health Care Organizations Call on CMS to Maintain Coverage for Medically Necessary Cancer Testing
Association for Molecular Pathology

Leading health care companies and organizations representing patients, providers, academic medical centers, laboratories, and diagnostic manufacturers urged the Centers for Medicare and Medicaid Services to revise its interpretation of the National Coverage Determination for Next Generation Sequencing.

Released: 22-Aug-2018 2:05 PM EDT
Association for Molecular Pathology Announces 2018 Award Recipients
Association for Molecular Pathology

AMP has announced the recipients of this year’s Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. These prestigious accolades will be presented in November during the AMP 2018 Annual Meeting & Expo in San Antonio, Texas.

Released: 21-Aug-2018 3:05 PM EDT
AMP Addresses Clinical Relevance of DNA Variants in Chronic Myeloid Neoplasms
Association for Molecular Pathology

AMP has published consensus, evidence-based recommendations to aid clinical laboratory professionals with the management of most Chronic Myeloid Neoplasms (CMNs) and development of high-throughput pan-myeloid sequencing testing panels.

Released: 27-Feb-2018 11:00 AM EST
AMP Publishes Recommendations for Clinical CYP2C19 Genotyping Allele Selection
Association for Molecular Pathology

AMP has published consensus, evidence-based recommendations to aid clinical laboratory professionals when designing and validating clinical CYP2C19 assays, promote standardization of testing across different laboratories and complement existing clinical guidelines.

   
Released: 16-Nov-2017 8:00 AM EST
AMP Issues Consensus Clinical Validation Guideline Recommendations for Next-Generation Sequencing Bioinformatics Pipelines
Association for Molecular Pathology

The Association for Molecular Pathology, the premier global, non-profit molecular diagnostics professional society, today published 17 consensus recommendations to help clinical laboratory professionals achieve high-quality sequencing results and deliver better patient care.

Released: 13-Sep-2017 1:05 PM EDT
The Association for Molecular Pathology Announces 2017 Award Recipients
Association for Molecular Pathology

September 5, 2017 – The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostics professionals, today announced the recipients of this year’s Jeffrey A. Kant Leadership and AMP Meritorious Service Awards.

   
Released: 19-Jul-2017 9:05 AM EDT
The Association for Molecular Pathology Announces Results of 2017 Leadership Elections
Association for Molecular Pathology

The Association for Molecular Pathology (AMP) has announced the results of its 2017 Leadership Elections.

Released: 22-Mar-2017 11:05 AM EDT
AMP Issues Best Practice Guidelines for Next-Generation Sequencing-Based Oncology Panel Validation
Association for Molecular Pathology

AMP has published consensus recommendations that will help clinical laboratory professionals achieve high-quality sequencing results and deliver better care for cancer patients

Released: 16-Dec-2016 11:05 AM EST
AMP Issues New Joint Guidelines to Standardize Interpretation and Reporting of Sequence Variants in Cancer
Association for Molecular Pathology

AMP has published guideline recommendations for both clinical laboratory professionals and oncologists that assess the status of next-generation sequencing (NGS)-based cancer tests and establish standardized classification, annotation, interpretation, and reporting conventions for somatic sequence variants.

Released: 21-Nov-2016 1:20 PM EST
AMP Applauds FDA’s Decision to Delay Final Regulatory Guidance for Laboratory Developed Procedures
Association for Molecular Pathology

AMP Applauds FDA’s Decision to Delay Final Regulatory Guidance for Laboratory Developed Procedures

Released: 19-Oct-2016 9:05 AM EDT
The Association for Molecular Pathology Explores New Technological Advancements to Improve Diagnosis and Optimize Treatment Selection for Invasive Infectious Diseases
Association for Molecular Pathology

AMP has announced a new report that examines how sophisticated technology advancements are being implemented to improve diagnosis and optimize treatment selection for multiple invasive, opportunistic and often deadly infectious diseases.


Showing results 1 – 50 of 135


close
0.22208